Close

Explore AI

Explore GPTs

Explore AI News

Explore AI Videos

Explore AI for Jobs

Latest Dixon Technologies AI Videos

Find the latest for Dixon Technologies company videos

Follow
... 22:6
Tally’s AI & Fintech Strategy: What’s Next for India’s OG Business Software?

moneycontrol

1+ months ago 17K views

Tally Solutions, established in 1986, has evolved from simple accounting software to a comprehensive business management platform, serving over 2.5 million businesses and 7 million users in India. Tally has navigated regulatory changes and technology shifts, including the recent surge in AI. The executive director, Nupur Goenka, emphasizes the company's commitment to agility, innovation, and connected business ecosystems while addressing challenges presented by AI in terms of data privacy and affordability. Continuous development of solutions like connected compliance and banking aims to enhance user experiences and leverage AI for better service delivery in the SME sector.
05:52 - 07:19

Key challenges for AI in Tally include data privacy and affordability in India.

Tally Solutions Big Data Analytics Finance
... 10:52
Revealed: Alex Koyfman's "$4 AI Firm" That Will Gain 96,000%

Dylan Rieger

1+ months ago 2K views

Alex Kman argues that a small tech firm has developed a breakthrough technology aimed at revolutionizing AI data centers, potentially leading to a stock increase of over 96,000%. Despite Kman's past recommendations showing mixed results, he indicates that this company, focusing on improving transceiver efficiency, is crucial due to the demands modern AI workloads place on infrastructure. The video reveals the identity of this company as Poet Technologies, which utilizes photonics to enhance data transmission speeds while reducing costs. Investors are cautioned about speculative nature and volatility associated with this stock.
04:52 - 04:59

Poet Technologies aims to make transceivers more efficient and cheaper.

Finance
... 8:4
$AITX, the Hot AI Stock | CEO Steve Reinharz Showcases ROAMEO & RADDOG LE2!

AITX

1+ months ago 1K views

Steve Reinharz, CEO and CTO of Artificial Intelligence Technology Solutions, introduces innovative products like RADDOG LE2 and ROAMEO, highlighting features such as advanced mobility, obstacle avoidance, and human interaction capabilities. These products are designed to enhance safety and operational efficiency in various environments. Reinharz emphasizes the significant interest from Fortune 500 companies, underscoring the potential impact of their technologies in the market. The upcoming ISC West event is noted as a platform for further showcasing these advancements, with high expectations for customer engagement and demand.
02:48 - 03:14

ROAMEO Gen 4 incorporates advanced sensors and mobility features.

Artificial Intelligence Technology Solutions Robotics AI Startups
... 11:13
Intel NEX SVP & GM Discusses vRAN Evolution & the Rise of AI in Telecom from MWC - Six Five Media

Six Five Media

1+ months ago 2K views

Intel has significantly impacted the Telecom industry through innovations like virtualized networks. The Zeon 6 CPUs, featuring enhanced AI capabilities, double the capacity while cutting power consumption by 70%. This transformative technology enables the integration of AI workloads within existing infrastructure, facilitating the deployment of software-defined networks. Customers are eager to modernize their operations, focusing on monetizing network investments in a rapidly changing landscape, particularly driven by AI advancements. The industry is shifting towards cloud-native architectures to ensure scalability and flexibility, transforming how networks are designed and operated.
Intel AI Trends Tech & Hardware
... 4:33
VIAVI on AI, Digital Twins, and the Future of Network Automation

Fierce Network TV

1+ months ago 2K views

The transition from telco to techco focuses on reducing friction in business operations through digitization and automation. This evolution emphasizes the importance of AI in network operations centers, driving efficiency and modern infrastructure management. The concept of 'dark knock' involves operating networks autonomously, requiring a deep understanding of operational intent. Lab as a service facilitates automated testing and operational continuity, ensuring issues can be addressed without compromising live networks. Digital twins are utilized for predictive analytics and operational planning, supporting the integration of AI in managing networks effectively.
03:58 - 04:21

Testing and validating AI functions have become critical for improving AI network management.

VIAVI Big Data Analytics Tech & Hardware
... 12:34
Top AI Growth Stock To Watch now - March 2025 - AI stock - Gorilla Technology GRRR stock $PLTR $NVDA

Paul Thomas Investing

1+ months ago 4K views

Gorilla Technologies' stock experienced significant volatility, dropping 30% before rallying back 50%. The company, which specializes in AI-driven security and IoT solutions, has shown remarkable growth, gaining around 400% in recent months. Their innovative technologies, including AI-powered facial recognition and surveillance, position them favorably within the market. Despite a low price-to-earnings ratio and a strong patent portfolio, challenges persist with transparency in financial reporting and workforce reductions. Upcoming agreements, such as the collaboration for the 'internet of forests,' indicate promising future prospects.
07:09 - 07:35

Gorilla signed a deal for the world's first Internet of Forests, enhancing environmental monitoring.

Gorilla Technology Machine Learning Finance
... 11:45
$AITX, the Hot AI Stock – CEO Steve Reinharz Unveils All Mobile Security Robotics Breakthroughs!

AITX

1+ months ago 5K views

Artificial Intelligence Technology Solutions (AITX) has achieved significant advancements over the last 14 months, enhancing product offerings and team capabilities. The company is pioneering humanoid and robotic technologies like the Romeo V4 security guard and Rad Dog LE2, reflecting strong mobility and functionality. Upcoming product deployments and anticipated press coverage aim to drive market interest and sales. Efforts focus on improving current products rather than extensive R&D, with an expectation of impactful results for fiscal year 2026. Navigating production costs amidst tariff situations showcases resilience and flexibility in their operations.
05:11 - 05:14

Launched Rad Dog LE2 with improvements based on deployment feedback.

AITX Robotics AI Startups
... 8:29
IPA Stock - AI Company to Watch (Update)

Blaze Capital

1+ months ago 10K views

Immuno Precise Antibodies (IPA), listed on NASDAQ as IPA, aims to revolutionize healthcare and drug discovery through its patented Lens AI technology. With over 90% of clinical drug developments failing, IPA addresses this challenge by accelerating drug discovery and integrating artificial intelligence with biological data. Their HFT patterns program introduces unique signature sequences, enabling the harmonization of complex biological data. The potential market for AI in drug discovery is projected to be worth $24.6 billion by 2029. The company is making strides in developing precision-targeted treatments, particularly for cancer, enhancing drug efficacy with fewer side effects.
04:01 - 04:06

In silico antibodies targeting tumor proteins show AI's efficacy in drug development.

Immunoprecise Antibodies Ltd Finance
... 8:29
IPA Stock - AI Company to Watch (Update)

Blaze Capital

1+ months ago 10K views

Immuno Precise Antibodies (IPA), listed on NASDAQ as IPA, aims to revolutionize healthcare and drug discovery through its patented Lens AI technology. With over 90% of clinical drug developments failing, IPA addresses this challenge by accelerating drug discovery and integrating artificial intelligence with biological data. Their HFT patterns program introduces unique signature sequences, enabling the harmonization of complex biological data. The potential market for AI in drug discovery is projected to be worth $24.6 billion by 2029. The company is making strides in developing precision-targeted treatments, particularly for cancer, enhancing drug efficacy with fewer side effects.
04:01 - 04:06

In silico antibodies targeting tumor proteins show AI's efficacy in drug development.

Immunoprecise Antibodies Ltd Finance